Evidence map›Paper›PMID 27713170›Full record

ArticleOncotarget2016

Gremlin inhibits UV-induced skin cell damages via activating VEGFR2-Nrf2 signaling.

Chao Ji, Jin-Wen Huang, Qiu-Yun Xu, Jing Zhang, Meng-Ting Lin, Ying Tu, Li He, Zhi-Gang Bi, Bo Cheng

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Tremella fuciformis polysaccharides alleviates UV-provoked skin cell damage via regulation of thioredoxin interacting protein and thioredoxin reductase 2.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Gremlin: a complex molecule regulating wound healing and fibrosis.Cellular and molecular life sciences : CMLS · 2021
    Review
  9. Article
  10. Article
  11. The Extract fromClinical interventions in aging · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Chao JiDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China.
Jin-Wen HuangDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China.
Qiu-Yun XuDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China.
Jing ZhangDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China.
Meng-Ting LinDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China.
Ying TuDepartment of Dermatology, The First Affiliated Hospital of Kunming Medical University, Yunnan Provincial Institute of Dermatology, Kunming 650032, Yunnan, China.
Li HeDepartment of Dermatology, The First Affiliated Hospital of Kunming Medical University, Yunnan Provincial Institute of Dermatology, Kunming 650032, Yunnan, China.
Zhi-Gang BiDepartment of Dermatology, BenQ Medical Center, Nanjing Medical University, Nanjing 210019, Jiangsu, China.
Bo ChengDepartment of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China.
First Affiliated Hospital of Fujian Medical University · CNFujian Medical University · CNFirst Affiliated Hospital of Kunming Medical University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultra Violet (UV) radiation induces reactive oxygen species (ROS) production, DNA oxidation and single strand breaks (SSBs), which will eventually lead to skin cell damages or even skin cancer. Here, we tested the potential activity of gremlin, a novel vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) agonist, against UV-induced skin cell damages. We show that gremlin activated VEGFR2 and significantly inhibited UV-induced death and apoptosis of skin keratinocytes and fibroblasts. Pharmacological inhibition or shRNA-mediated knockdown of VEGFR2 almost abolished gremlin-mediated cytoprotection against UV in the skin cells. Further studies showed that gremlin activated VEGFR2 downstream NF-E2-related factor 2 (Nrf2) signaling, which appeared required for subsequent skin cell protection. Nrf2 shRNA knockdown or S40T dominant negative mutation largely inhibited gremlin-mediated skin cell protection against UV. At last, we show that gremlin dramatically inhibited UV-induced ROS production and DNA SSB formation in skin keratinocytes and fibroblasts. We conclude that gremlin protects skin cells from UV damages via activating VEGFR2-Nrf2 signaling. Gremlin could be further tested as a novel anti-UV skin protectant.

Indexed as

Cells, CulturedCytoprotectionDNA Breaks, Single-StrandedDNA DamageFibroblastsHumansIntercellular Signaling Peptides and ProteinsKeratinocytesNF-E2-Related Factor 2Reactive Oxygen SpeciesRNA, Small InterferingSignal TransductionSkinUltraviolet RaysVascular Endothelial Growth Factor Receptor-2GREM1 protein, humanIntercellular Signaling Peptides and ProteinsKDR protein, humanNFE2L2 protein, humanNF-E2-Related Factor 2Reactive Oxygen SpeciesRNA, Small InterferingVascular Endothelial Growth Factor Receptor-2gremlinNrf2skin cell damageultra violet (UV)VEGFR2

Identifiers

PMID27713170
PMCPMC5356696
OpenAlexW2528040020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.